2025 Cell Industry Conference (3 Shanghai June Shenzhen October Suzhou)

COTV GLOBAL LIVE

2025 Cell Industry Conference

March Shanghai June Shenzhen October Suzhou

☆ Conference Overview

In recent years, with the rapid development of biological cell technology and industry worldwide, cell therapy and clinical translation have become important topics for the development of China's "14th Five Year Plan" health security. From 2023 to 2024, governments across the country have introduced a series of policies to promote the development of the cell industry, injecting unprecedented vitality into this field. A series of policies promoting the development of the cell industry have been intensively introduced from the national to local levels, providing strong guarantees and support for the development of the cell therapy field. In the future, with the continuous advancement of technology and the gradual improvement of policies, the cell therapy industry will accelerate into the fast lane of the billion dollar health industry. The 2025 Cell Industry Conference will be held in Shanghai in March, Shenzhen in June, and Suzhou in October. The conference will have exhibition areas, main forums, and multiple sub forums, focusing on cutting-edge technologies such as cell therapy, immune cell therapy, stem cells, anti-aging and regenerative medicine, gene therapy, gene editing, exosomes, extracellular vesicles, organoids, organ chips, and single-cell omics. Through various forms such as theme reports, roundtable discussions, and celebrity dialogues, experts and scholars from all aspects of the industry chain, as well as representatives of leading enterprises that have made significant progress recently, will be invited to present a unique cell industry event for the industry.

☆ Cooperative units

Jiangsu Biotechnology Association

Shenzhen Cell Therapy Technology Association

Asia Pacific Society for Precision Anti Aging Medicine

Guangdong Hong Kong Macao Greater Bay Area Precision Medicine Research Institute (Guangzhou)

Cell and Gene Therapy Research Center of Southern University of Science and Technology

Wuhan Donghu National Independent Innovation Demonstration Zone Biomedical Industry Association

☆ Selected topics for the conference：

● Cell Session

Progress in Cell Therapy Research and Development | Industrialization of Cell Therapy Research and Development | Innovative Research and Development of Immune Cell Therapy | Preclinical and Clinical Development of Immune Cell Therapy | Cell Technology and Health Management | mRNA mediated in vivo edited CAR-M cells for solid tumor immunotherapy | New generation CAR macrophage tumor immunotherapy technology | In situ CAR synergistic immunotherapy technology based on circular RNA | Universal cell design and modification | Early development of TCR-T, TIL, CAR-NK, and gamma delta T | Early development of CAR-T solid tumors | Early development of CAR-T autoimmunity

● Stem Cell Session

Clinical and translational applications of stem cells | Stem cell function and disease research | Stem cell and disease modeling, drug screening | Stem cell exosomes | Regenerative medicine and stem cell technology | Mesenchymal stem cell MSC | Induced multifunctional stem cell iPSC | Clinical application of autologous adipose derived stem cells

Cell and Gene (CGT) Session

Key Points and Review of Cell Gene Therapy CMC | Future and Challenges of Cell Gene Therapy | Cell Engineering and Organ Reconstruction | Development and Industrialization of Cell Therapy | Gene Therapy and Delivery Technology | Frontiers of Blood and CGT | Gene Editing and Delivery Technology

● Extracellular vesicle&exosome session

Advances and challenges in cutting-edge technologies of extracellular vesicles | Extracellular vesicles and clinical disease diagnosis and treatment | Development of engineered exosomes and delivery systems | Exploration of the industrialization direction of extracellular vesicles | Extracellular vesicle therapy for CNS diseases | Extracellular vesicles and dermatology | The path of extracellular vesicle drug development

● Organ class session

Development and application of cutting-edge technologies in organoids | Organoid and organo chip technology and drug screening | Organoid and organo chip and disease modeling | Organoid and organo chip biomanufacturing | Application of organoids in precision medicine | Cultivation and quality control of organoids | Application of organoids and organo chips in preclinical drug development

Anti aging and Regenerative Medicine Special Session

Anti aging and Regenerative Medicine | Aging and Immunity | Cellular Aging and Intervention | Healthy Aging and Longevity | Anti aging and Functional Medicine | Precision Medicine Anti aging | Emerging Anti aging Technologies

Single cell session multi omics technology innovation | Spatiotemporal dynamics | Bioinformatics big data | Proteomics and immunology | Metabolomics and microbiology | Spatiotemporal genomics | Clinical translational medicine

☆ Attendees:

Deans, hospital managers, chief physicians, associate chief physicians, attending physicians of various departments such as oncology, oncology surgery, biotherapy, hematology, pathology, assisted reproductive technology, and laboratory medicine in major hospitals across the country, as well as experts, researchers, pharmaceutical companies, etc. who conduct research in related fields;

Research institutes, biopharmaceutical companies, technical service agents and investment institutions, clinical doctors, etc;

Professors, researchers, associate researchers, and majors in life sciences, pharmacy, medicine, immunology, etc. from well-known universities;

● Upstream suppliers of cell and tumor antibody immunotherapy, diagnostic reagent and equipment service providers, technology and equipment instrument providers, IT big data solution providers, etc;

Technical personnel and R&D directors from gene therapy, gene editing, gene sequencing, gene testing companies, biotechnology companies, etc;

Institutions, enterprises, companies in the upstream, midstream, and downstream industry chains of cell storage and therapy, as well as CROs, CMOs, and others in the field of precision medicine;

CEO and pharmaceutical R&D leader: experts, clinical researchers, practicing physicians, graduate students, as well as medical product researchers and manufacturers in the fields of antibody immunotherapy drug development, immune cell therapy and product development, oncolytic viruses, therapeutic vaccines, small molecule immunotherapy drugs, cell therapy and regenerative medicine;

Government agencies and representatives, industrial parks, investment promotion bureaus, investment incubation institutions, consulting and training institutions, banks, lawyers, intellectual property, securities companies, etc.

☆ Contact information:

Shanghai Shunzhan Exhibition Service Co., Ltd

Address: Room 502, Xinghui Building, No. 1197 Husong Road, Songjiang District, Shanghai

Contact: Ms. Yu Jing 13601687152 (WeChat)